Click here to access the analysis Suboxone Tab.

In association with Indivior we are pleased to be able to offer this additional discount, which will make it more profitable for your pharmacy to stay with Suboxone and delay the required brand change (which your patient will appreciate) until closer to the end of the dual listing period around March 2020.

Margins and Profits in Pharmacy are a necessity for survival and we encourage you to stay with Suboxone for as long as possible.

Deal is on-going with no minimum quantity

Together we can make this a seamless and painless transition.

We thank you in anticipation of your ongoing support.

About The Author